As AI-assisted morphology becomes more integrated into routine hematology, laboratories need more than automated cell classification. Cell images must be available for professional review, while analyzers must also meet daily testing and maintenance requirements. At MEDICA 2026, we will spotlight O-Cyte 1, our automated hematology analyzer combining AI × CBM (Complete Blood Morphology) analysis with scalable throughput and service-ready design.

O-Cyte 1: Advancing Morphology Intelligence with AI × CBM

O-Cyte 1 performs CBC testing with 7-part white blood cell differentiation, integrating high-resolution cell imaging and AI-assisted cell classification within the same analyzer. Laboratory professionals can review corresponding cell images alongside numerical results when further evaluation is needed.

This approach reflects our vision for the fourth generation of hematology analysis: making morphology intelligence more consistent, reviewable and scalable across routine hematology workflows.

Scalable Throughput. Simpler Maintenance and Service.

Designed for changing workloads and everyday laboratory operation, O-Cyte 1 delivers up to 60 tests per hour as a standalone analyzer, scaling to 360 tests per hour with six connected units.

Its integrated reagent kit and consumable-contained fluid-contact components help simplify reagent handling and reduce routine maintenance. Built-in self-checks and replaceable modules support more straightforward troubleshooting and servicing.

For IVD distribution partners, scalable configurations offer flexibility to serve laboratories with different testing volumes and support future capacity expansion. Simplified reagent management and modular design can also ease technical support and after-sales service.

Explore Ozelle’s Hematology Portfolio at MEDICA 2026

Alongside O-Cyte 1, we will present EHBT-75, combining 7-diff hematology with cell imaging and morphology analysis, and EHBT-50, integrating hematology, immunoassay and dry biochemistry in one compact platform.

Visitors can also explore Open Dx, our AI Workbench for AI-assisted report review and result sharing. Together, our solutions address different testing needs and clinical settings.

Join us at MEDICA 2026, November 16–19, in Hall 1, Booth D63 at Messe Düsseldorf. Explore O-Cyte 1 and our diagnostic portfolio firsthand, and meet our team to discuss potential distribution partnerships.